JPRN-UMIN000042519招募中未知
Remimazolam and Body Weight - R-BW
Division of Anesthesia, Shin Sapporo Orthopaedic Hospital0 个研究点目标入组 60 人开始时间: 2020年11月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients getting hemodialysis
研究者
相似试验
尚未招募
不适用
Investigation of the Effect of Remimazolam on Circulatory Management in Transurethral Resection of Bladder Tumor with 5-Aminolevulinic AcidMuscle layer non-invasive bladder cancerJPRN-UMIN000052910Chiba University200
已完成
4 期
Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal AnesthesiaArthritis KneeArthritis HipNCT05760534Seoul National University Hospital110
进行中（未招募）
不适用
/AThe objective is to explore the efficacy of pharmacological weight reduction compared with CPAP treatment in patients with moderate to severe obstructive sleep apnea (OSA).MedDRA version: 12.0Level: LLTClassification code 10055577Term: Obstructive sleep apnea syndromeEUCTR2009-015859-24-SEThe Sahlgrenska Academy, University of Gothenburg90
招募中
不适用
Observational study of the effects of remimazolam on MEP in spinal surgerySpine surgeryJPRN-UMIN000042367Hamamatsu University School of Medicine150
已完成
2 期
Japanese Dose-Response Study of Rimonabant in Obese PatientsObesityNCT00459004Sanofi527